Caitong International Asset Management Co., LTD Humacyte, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Humacyte, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 1,508 shares of HUMA stock, worth $5,896. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,508
Previous 1,508
-0.0%
Holding current value
$5,896
Previous $7.62 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
171Shares Held
41MCall Options Held
553KPut Options Held
942K-
Black Rock Inc. New York, NY7.14MShares$27.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$21.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.61MShares$18 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA2.85MShares$11.1 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$8.35 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $403M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...